GI
DERM icon

GAMMA Investing’s Journey Medical DERM Stock Holding History

GAMMA Investing’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-101
Closed -$474 – 4166
2026
Q1 		$474 Sell
101
-81
-45% -$629 ﹤0.01% 3959
2025
Q4 		$1.4K Buy
182
+18
+11% +$141 ﹤0.01% 3702
2025
Q3 		$1.17K Buy
+164
New +$1.19K ﹤0.01% 3582

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's DERM Position: Q2 2026 in Review

GAMMA Investing sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 101 shares — an estimated $474 sold.

GAMMA Investing first reported a position in DERM in Q3 2025 and held it in 3 quarters. The position peaked at $1.4K in Q4 2025. 4 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • GAMMA Investing reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • GAMMA Investing sold 101 Journey Medical shares in Q2 2026, an estimated $474.
  • GAMMA Investing first reported a position in Journey Medical in Q3 2025 and held it in 3 quarters.
  • GAMMA Investing's Journey Medical position peaked at $1.4K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.